Valuation: Sinopharm Group Co. Ltd.

Capitalization 58.28B 65.91B 8.43B 7.11B 6.5B 6.18B 11.46B 765B 11.84B 74.99B 29.94B 368B 31.62B 30.97B 1,293B P/E ratio 2025 *
7.91x
P/E ratio 2026 * 7.05x
Enterprise value 58.97B 66.69B 8.53B 7.19B 6.58B 6.25B 11.59B 774B 11.98B 75.88B 30.3B 372B 31.99B 31.34B 1,308B EV / Sales 2025 *
0.1x
EV / Sales 2026 * 0.1x
Free-Float
42.99%
Yield 2025 *
3.81%
Yield 2026 * 4.12%
1 day-1.12%
1 week+0.67%
Current month+1.15%
1 month+2.13%
3 months+5.18%
6 months+11.86%
Current year+8.64%
1 week 20.82
Extreme 20.82
21.52
1 month 20.14
Extreme 20.14
21.52
Current year 19.31
Extreme 19.31
21.52
1 year 16.74
Extreme 16.74
21.66
3 years 16.02
Extreme 16.02
28.45
5 years 14.6
Extreme 14.6
28.45
10 years 14.6
Extreme 14.6
45.65
Manager TitleAgeSince
President 56 2024-08-26
Corporate Secretary 56 -
Director of Finance/CFO 62 2010-04-30
Director TitleAgeSince
Director/Board Member 53 2010-04-30
Director/Board Member 56 2014-09-20
Director/Board Member 54 2017-08-31
Change 5d. change 1-year change 3-years change Capi.($)
-1.12%+0.67%+5.81%+5.07% 8.53B
+1.92%+15.96%+56.16%+159.75% 115B
+1.81%+8.41%+74.66%+182.22% 51.83B
+0.32%-1.27%+9.54% - 25.13B
-0.19%+1.02%+5.59%-25.99% 9.3B
-0.06%+0.58%-14.34%-7.05% 8.36B
0.00%+3.29%+22.49%+34.36% 6.54B
-1.98%-9.47%-9.89%+28.89% 6.12B
-30.73%-27.74% - - 3.91B
+1.15%+4.26%+32.55%+71.31% 3.93B
Average -2.95%+2.03%+20.29%+56.07% 23.82B
Weighted average by Cap. +0.83%+7.15%+45.84%+134.68%

Financials

2025 *2026 *
Net sales 586B 662B 84.74B 71.42B 65.37B 62.11B 115B 7,690B 119B 754B 301B 3,697B 318B 311B 12,991B 616B 697B 89.1B 75.09B 68.73B 65.3B 121B 8,086B 125B 793B 316B 3,888B 334B 327B 13,659B
Net income 7.34B 8.3B 1.06B 895M 819M 778M 1.44B 96.34B 1.49B 9.44B 3.77B 46.32B 3.98B 3.9B 163B 8.15B 9.22B 1.18B 994M 910M 865M 1.6B 107B 1.66B 10.49B 4.19B 51.48B 4.42B 4.33B 181B
Net Debt 689M 779M 99.7M 84.03M 76.91M 73.07M 135M 9.05B 140M 887M 354M 4.35B 374M 366M 15.29B 1.34B 1.51B 193M 163M 149M 142M 263M 17.55B 272M 1.72B 687M 8.44B 725M 711M 29.65B
Logo Sinopharm Group Co. Ltd.
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business.The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.
Employees
108,217
Date Price Change Volume
26-02-11 21.12 $ -1.12% 10,124,380
26-02-10 21.36 $ +0.95% 11,834,400
26-02-09 21.16 $ -0.28% 5,724,777
26-02-06 21.22 $ 0.00% 4,615,141
26-02-05 21.22 $ +0.47% 5,094,718
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
18.67CNY
Average target price
20.35CNY
Spread / Average Target
+8.96%

Quarterly revenue - Rate of surprise